Volume 19, Issue 3, Pages (March 2014)

Slides:



Advertisements
Similar presentations
Could fasting while receiving chemotherapy be beneficial?
Advertisements

Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Volume 10, Issue 4, Pages (October 2009)
Michael R. MacArthur, James R. Mitchell  Cell Metabolism 
Michael R. MacArthur, James R. Mitchell  Cell Metabolism 
Volume 14, Issue 3, Pages (September 2011)
Volume 22, Issue 6, Pages (December 2015)
Volume 11, Issue 1, Pages (January 2010)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 11, Issue 5, Pages (May 2010)
Ying Li, Wei Xu, Michael W. McBurney, Valter D. Longo  Cell Metabolism 
Volume 13, Issue 2, Pages (February 2011)
Volume 18, Issue 2, Pages (February 2016)
Volume 15, Issue 2, Pages (February 2012)
Volume 22, Issue 1, Pages (July 2015)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Independent Control of Aging and Axon Regeneration
Volume 17, Issue 5, Pages (May 2013)
Volume 29, Issue 4, Pages (April 2016)
Volume 26, Issue 3, Pages e8 (September 2017)
Volume 23, Issue 4, Pages (April 2016)
Volume 30, Issue 1, Pages (July 2016)
Volume 18, Issue 6, Pages (December 2013)
Volume 3, Issue 4, Pages (April 2003)
Volume 20, Issue 1, Pages (July 2014)
Branching Out for Detection of Type 2 Diabetes
Volume 20, Issue 1, Pages (July 2014)
Volume 26, Issue 3, Pages e8 (September 2017)
Volume 20, Issue 2, Pages (July 2017)
Volume 16, Issue 7, Pages (August 2016)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 143, Issue 5, Pages (November 2010)
Volume 13, Issue 4, Pages (April 2011)
Volume 9, Issue 2, Pages (February 2009)
Volume 16, Issue 4, Pages (October 2012)
Mitochondria and Cancer
Replicative and Chronological Aging in Saccharomyces cerevisiae
Volume 10, Issue 5, Pages (November 2009)
Sir2 Blocks Extreme Life-Span Extension
Volume 9, Issue 1, Pages (January 2009)
Volume 1, Issue 4, Pages (April 2005)
Syntaxin 4 Overexpression Ameliorates Effects of Aging and High-Fat Diet on Glucose Control and Extends Lifespan  Eunjin Oh, Richard A. Miller, Debbie C.
Valter D. Longo, Satchidananda Panda  Cell Metabolism 
Volume 27, Issue 2, Pages e4 (February 2018)
Volume 14, Issue 4, Pages (October 2011)
High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic Dysfunction  Angeliki Chalkiadaki, Leonard Guarente 
Volume 15, Issue 2, Pages (February 2012)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Volume 14, Issue 5, Pages (November 2011)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Circadian Dysfunction Induces Leptin Resistance in Mice
Volume 9, Issue 6, Pages (June 2009)
Volume 12, Issue 3, Pages (September 2010)
Lipin, a lipodystrophy and obesity gene
TOR Regulation: Sorting out the Answers
Volume 4, Issue 5, Pages (November 2006)
Luigi Fontana, Linda Partridge  Cell 
Epigenetic Silencing Mediates Mitochondria Stress-Induced Longevity
Sir2 Blocks Extreme Life-Span Extension
Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.
Sex Differences in Lifespan
Should I Stay or Should I Go: A Clash of α-Cell Identity
Of Mice and Men: Not ExAKTly the Same?
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 16, Issue 3, Pages (September 2012)
Volume 6, Issue 6, Pages (December 2007)
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

Volume 19, Issue 3, Pages 407-417 (March 2014) Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population  Morgan E. Levine, Jorge A. Suarez, Sebastian Brandhorst, Priya Balasubramanian, Chia-Wei Cheng, Federica Madia, Luigi Fontana, Mario G. Mirisola, Jaime Guevara-Aguirre, Junxiang Wan, Giuseppe Passarino, Brian K. Kennedy, Min Wei, Pinchas Cohen, Eileen M. Crimmins, Valter D. Longo  Cell Metabolism  Volume 19, Issue 3, Pages 407-417 (March 2014) DOI: 10.1016/j.cmet.2014.02.006 Copyright © 2014 Elsevier Inc. Terms and Conditions

Cell Metabolism 2014 19, 407-417DOI: (10.1016/j.cmet.2014.02.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Association between Protein Intake and Mortality Using Cox proportional hazard models, statistically significant (p < 0.05) interactions between age and protein group were found for all-cause and cancer mortality. Based on these models, predicted remaining life expectancy was calculated for each protein group by age at baseline. Overall, low protein appears to have a protective effect against all-cause and cancer mortality prior to age 66, at which point it becomes detrimental. No significant interactions were found for cardiovascular disease (CVD) and diabetes mortality. Cell Metabolism 2014 19, 407-417DOI: (10.1016/j.cmet.2014.02.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Serum IGF-1 Levels in Respondents 50–65 and 66+ Reporting Low, Moderate, or High Protein Intake IGF-1 in respondents ages 50–65 is significantly lower among those with low protein intake when compared to high (p = 0.004). For those ages 66+ the difference between high and low intake becomes marginally significant (p = 0.101). The cohort for which IGF-1 levels were calculated includes 2,253 subjects. Of those ages 50–65 (n = 1,125), 89 were in the low protein category, 854 were in the moderate protein category, and 182 were in the high protein category. Of those ages 66+ (n = 1,128), 80 were in the low protein category, 867 were in the moderate protein category, and 181 were in the high protein category. Data points represent the mean ± SEM. ∗p < 0.01. Cell Metabolism 2014 19, 407-417DOI: (10.1016/j.cmet.2014.02.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Effects of Proteins and Amino Acids on Tumor Progression or DNA Damage in Mouse and S. cerevisiae Models (A) Tumor incidence in 18-week-old male C57BL/6 mice implanted with 20,000 melanoma (B16) cells and fed either a high protein (18%; n = 10) or low protein (4%; n = 10) diet. (B) B16 tumor volume progression in 18-week-old male C57BL/6 mice fed either a high protein (n = 10) or low protein (n = 10) diet. (C) IGF-1 at day 16 in 18-week-old male C57BL/6 mice fed either a high protein (n = 5) or low protein (n = 5) diet. (D) IGFBP-1 at day 16 in 18-week-old male C57BL/6 mice fed either a high protein (n = 10) or low protein (n = 10) diet. (E) B16 melanoma tumor progression in 10-month-old female GHRKO mice (n = 5) versus age-matched littermate controls (Ctrl; n = 7). (F) Tumor incidence in 12-week-old female BALB/c mice implanted with 20,000 breast cancer (4T1) cells and fed either a high protein (18%; n = 10) or low protein (7%; n = 10) diet. (G) 4T1 breast cancer progression in 12-week-old female BALB/c mice fed either a high protein (n = 10) or low protein (n = 10) diet. (H) IGF-1 at day 16 in 12-week-old female BALB/c mice fed either a high animal protein (n = 5) or low animal protein (n = 5) diet. (I) IGFBP-1 at day 16 in 12-week-old female BALB/c mice fed either a high animal protein (n = 10) or low animal protein (n = 10) diet. (J) IGF-1 at day 16 in 12-week-old female BALB/c mice fed either a high soy protein (n = 5) or low soy protein (n = 5) diet. (K) IGFBP-1 at day 16 in 12-week-old female BALB/c mice fed either high soy protein (n = 10) or low soy protein (n = 10) diet. (L and M) Survival (L) and DNA mutation frequency (M) of yeast exposed to a 0.5×, 1×, or 2× concentration of a standard amino acid mix. (N) PDS and STRE activity in yeast grown in media containing only Trp, Leu, and His compared to those grown in the presence of all amino acids. (O) RAS2 deletion protects against oxidative stress-induced genomic instability measured as DNA mutation frequency (Canr) in wild-type (DBY746) and ras2Δ mutants chronically exposed to 1 mM H2O2. (P) A model for the effect of amino acids on aging and genomic instability in S. cerevisiae. Amino acids activate the Tor-Sch9 and Ras-cAMP-PKA pathway also activated by glucose and promote age- and oxidative stress-dependent genomic instability in part via reduced activity of Gis1 and Msn2/4. In all graphs, data points represent the mean of the biological replicates ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. Cell Metabolism 2014 19, 407-417DOI: (10.1016/j.cmet.2014.02.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Effect of Protein Intake on Body Weight in Young and Old Mice (A) Young (18-week-old; n = 10) and old (24-month-old; n = 6) C57BL/6 mice fed a high (18%) protein diet. (B) Young (18-week-old; n = 10) and old (24-month-old; n = 6) C57BL/6 mice fed a low (4%) protein diet. Data points represent mean ± SEM. Cell Metabolism 2014 19, 407-417DOI: (10.1016/j.cmet.2014.02.006) Copyright © 2014 Elsevier Inc. Terms and Conditions